Background Tom focuses on all phases of pharmaceutical drug development. He has experience working with both large pharmaceutical companies and smaller biotechnology firms to develop and implement comprehensive non-clinical, clinical and regulatory strategies. With his background in pharmacology and expertise in medical and scientific writing, Tom has been instrumental in the preparation of Integrated Development Plans, Investigator’s Brochures, Clinical Protocols, Pre-IND briefing documents, INDs, and CTDs. Tom has substantial experience in the organization, preparation, and critical quality review of drug development documentation necessary for IRB and regulatory review processes. More recently, Tom has taken on greater project management responsibilities for our drug development projects and serves as a study monitor on non-clinical GLP studies. Tom is a member of the Drug Information Association (DIA) and serves on the Executive Committee of the Drug Discovery, Drug Development and Regulatory Affairs division of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Education Tom earned a PhD in Pharmacology and an MBA from the Pennsylvania State University, with a concentration in Intellectual Property Management. He completed his post-doctoral training at the University of Pennsylvania, where he focused on novel drug delivery therapeutics. He also holds a BS in Biology from Washington and Lee University. On the Personal Side Tom lives in Center City Philadelphia with his wife Nicole. In his free time, Tom enjoys golfing, traveling, and working toward his next softball team league championship. You can reach Tom directly at tstover@swiftwater.com.